319
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Terms Index

Pages 239-242 | Published online: 02 Dec 2008

Terms Index

20(S)-ginsenoside Rh1, 222

23-hydroxybetulinic acid, 293

25 dihydroxyvitamin D3, 160

5-Fluorouracil, 244

Absorption, 51, 324, 310

Acute renal failure, 266

Amphotericin B, 76

Analytical, 62, 66, 67, 68, 69, 72, 74, 73, 75, 76, 77, 80, 81, 82, 84, 85, 115, 119, 169, 181, 186, 198, 200, 201, 204, 218, 219, 243, 245, 255, 258, 259, 268, 285, 318

Andrographis paniculata, 245

Andrographolide, 160, 298

Anthraquinones, 220

Anti-inflammation, 127

Aralia continentalis Heme oxygenase-1, 153

Artemisinin, 154

Arthritis, 323

Atomoxetine, 247

Baculovirus expression system, 104

Baicalein, 56, 148

Baicalin, 148, 225

Belotecan, 271

Berberine, 148, 223

Biapenem, 288

Biliary Drainage Models, 294

Bioaccumulation, 117

Bioavailability, 52, 62, 71, 74, 80, 86, 87,115, 116, 118, 122, 136, 231, 245, 266, 269, 272, 276, 290, 291, 324

Bioequivalence, 272

Biomarkers, 67, 173

bisphenol A, 176

Blood-Brain Barrier, 292, 322

Brain Transport, 292

Caco-2, 88, 148, 149

Caco-2 Cells, 339

Caffeic Acid, 59

Cardamonin, 218

Carisoprodol, 234

Cat, 92

Cell Lysate, 75

Chemotherapy, 293

Cinnamic acid, 89

Classification Mutagenicity, 184

Clearance Prediction, 101, 176, 182, 183, 226, 276, 319, 335

Clinical Assessment, 111

Computed Tomography, 99

Conjugation Reactions and Enzymes, 59, 90, 159, 176, 193, 196, 211, 225, 327

Coptidis Rhizoma, 194

Coumarin, 97

Cryptotanshinone, 52

Cyanin chloride, CYP1A1, 95

Cynomolgus Monkey, 120, 221, 303

CYP enzymes, 105

CYP2A13, 214

CYP2D6, 98

CYP3A4, 160

Cytochrome P450, 46, 49, 50, 55, 58, 60, 65, 66, 92, 93, 94, 95, 97, 100, 101, 102, 105, 107, 108, 109, 110, 112, 130, 131, 135, 137, 138, 143, 145, 151, 152, 155, 156, 157, 158, 160, 161, 166, 167, 177, 178, 183, 185, 186, 187, 188, 189, 190, 193,203, 204, 211, 212, 214

Daidzein, 255

Daidzin, 255

Danggui, 156

Danshen Extract, 105

Dealkylation Tool and Mass Defect Filter, 205

Dertromethorphan, 84

Dextrophan, 84

Diet, 109

Differences in metabolism (species, gender, age, diseases), 45, 49, 60, 108, 109, 110, 112,166, 176, 203, 227, 235, 236, 237, 238, 261, 323

Disposition, 53, 114, 116, 117, 118, 126, 130, 182, 219, 244, 251, 252, 255, 265, 267, 270, 295, 299, 300, 314, 325, 328, 336, 273, 320, 321, 327

Distribution, 119

DNA Methylation, 167

Double-peak Phenomenon, 294

Doxazosin, 72

Drug Discovery and Development, 67, 69, 88, 110, 115, 118, 122, 124, 125, 126, 127, 147, 171, 177, 180, 181, 184, 186, 187, 210, 251, 259, 263, 265, 267, 270, 273, 291, 315, 319

Drug Interaction, 44, 55, 63, 65, 66, 131, 132, 133, 134, 135, 136, 137, 138, 143, 145, 146, 151, 152, 155, 157, 158, 159, 160, 194, 228, 229, 252, 259, 286, 300, 309, 320, 324, 330, 336, 339

Drug-drug Interactions, 223

Early Atherosclerosis, 174

Effective Components, 119

Elimination, 52

Enzyme Induction, 46, 55, 58, 93, 107, 108, 137, 138, 143, 145, 153, 154, 155, 177, 189, 226, 304

Enzyme Inhibition/Inactivation, 44, 55, 92, 93, 133, 134, 135, 143, 145, 151, 152, 156, 157, 158, 159, 160, 187, 193, 215, 226

Enzyme Kinetics, 183

Estradiol, 159

Excretion, 299

Extrahepatic metabolism, 91, 215, 196, 97, 225

Fenofibrate, 221

First-pass elimination, 223

Flavin-containing Monooxygenase 3, 227

Folic Acid Induced Acute Renal Failure, 271

Forsythiaside, 74

Fucoidan, 163

Furan, 169

Gallic acid, 83

Gamma-Hydroxybutyrate (GHB), 252

GC/MS, 174

GC/TOF/MS, 173

Gemfibrozil, 303

Gemifloxacin, 289

Gene Expression and Regulation, 46, 50, 55, 57, 58, 61, 95, 112, 153, 162, 163, 164, 165, 166, 168, 179, 227, 232, 239, 240, 304, 314, 331, 337

Genomics/Metabonomics/Proteomics, 50, 57, 60, 61, 169, 171, 172, 173, 174, 231, 239, 240

Ger-Gen-Chin-Lien Tang, 140

Ginsenoside Rb1, 304

Global Detection, 81

Glycyrrizic acid, 149

GSH trapping, 200

Half life, 124

Hamster, 174

Harmine Hydrochloride, 242

Hematoporphyrin, 264

Heme Oxygenase-1, 304

Hepatic Blood Flow, 120

Hepatic Transporters, 317

Hepatic Uptake Biliary Excretion, 315

Hepatocytes, 49, 53, 99, 115, 128, 155, 167, 178, 180, 211, 323, 335

Herbal Drugs, 81

Herb-drug Interaction, 105

High Performance Liquid Chromatography, 288

High Throughput Techniques, 65, 69, 78, 198, 204, 181, 200, 205, 251, 258, 283, 284

HPLC, 75, 76, 83, 289

Huang-Qin Tang, 339

HUVECs, 75

Hypercholesterolemia, 174

In Silico, 131, 133, 184

In Situ Closed Loop Models, 294

In Vitro Techniques, 48, 51, 63, 65, 66, 67, 83, 85, 88, 91, 93, 104, 131, 146, 147, 148, 152, 155, 156, 159, 167, 171, 179, 180, 186, 196, 198, 201, 210, 218, 256, 291, 309, 311

In Vivo, 59, 83

Inflammation, 321

Inhibitor, 293

Integrated LC-MS Metabonomics, 206

Intestinal Absorption, 294, 333

Isoflavone Pueraria lobata, 255

Isoline, 216

Itraconazole, 76

Ketoprofen, 51

KR-33028, 254

LC-(ESI)-IT-TOF/MS, 82

LC/MS, 59, 216

LC/MS/MS, 70, 74, 81, 84, 120, 224

Ligand Binding, 175

Liposome, 124

Liver, 56

Liver toxicity, 188

Lung Cancer, 264

Mai-Luo-Ning Injection, 81

Mass Spectrometry, 154, 170

Mechanisms of Xenobiotic Toxicities, 163, 169, 189, 208, 322

Metabolic Profiling, 44, 45, 48, 59, 60, 81, 101, 110, 111, 114, 169, 170, 173, 176, 195, 197, 198, 199, 200, 201, 202, 204, 205, 206, 207, 210, 211, 212, 226, 245, 259, 311

Metabolism, 44, 45, 47, 49, 56, 63, 66, 79, 80, 85, 91, 92, 93, 108, 109, 110, 111, 112, 119, 131, 145, 151, 152, 170, 177, 178, 183, 186, 187, 188, 189, 195, 196, 197, 200, 201, 202, 203, 208, 209, 210, 211, 212, 213, 214, 215, 216, 218, 221, 222, 223, 224, 228, 232

Metabolite Profiling, 56

Metabolite Synthesis, 90

Metabolites, 255

Metabolites Analysis, 81

Metabonomics, 173, 174

Metformin, 336

Methotrexate, 139, 140, 141, 330

Methyl Protodioscin,

Methylphenidate, 247

Microdialysis, 247

MIST, 111

MMP-9, 292

MRPs, 330

Multidrug Resistance-associated Proteins, 139

Multivariate statistical analysis, 174

Mycotoxin, 91

Myotoxicity, 303

Nano-particle micelle of doxorubicin, 295

Nanoparticles, 264

Natural products, 156

Neurotransmitter, 247

Nicotine, 170

Non-P450 phase I enzymes, 49, 168, 212, 225, 227

Nucleoside Transporter, 325

Nude mice, 244

Oral Drug Absorption, 51

Organic anion transporters, 139

Oridonin, 71

Oxidative Stree, 292

P450 Inhibitor, 223

Paeoniflorin, 149, 257

Paracetamol, 84, 103

Paraquat, 117

Peroxidases, 188

P-glycoprotein, 75, 333, 339

P-gp, 293

Pharmacogenetics, 57, 61, 98, 101, 227, 228, 231, 232, 235, 236, 237, 238, 240, 262, 326, 329, 340,

Pharmacokinetic Study of Breviscapine Naristilla and Nasal Gelata, 297

Pharmacokinetics, 89, 121, 150, 222, 234, 241, 255, 271, 289, 290, 293, 296

Pharmacokinetics and Pharmacodynamics, 52, 53, 60, 62, 63, 68, 71, 72,80, 88, 98, 115, 121, 123, 139, 144, 147, 151, 175, 181, 182, 185, 215, 220, 228, 231, 235, 236, 237, 238, 242, 243, 244, 246, 249, 250, 252, 253, 254, 256, 257, 259, 260, 262, 263, 265, 267, 270, 273, 275, 277, 278, 280, 2

Phase I, 56, 59

Phase II, 56, 59

Phenytoin, 142

Physiologically based pharmacokinetic (PBPK) models, 182

PK/PD modeling, 248

Plasma, 70, 268

PLC Danshen Injection, 290

Polyethylene glycol, 124

Polymers, 244

Polymorphism, 258

Poly-organophosphazene drug delivery system, 253

Prodrug, 241

Protein Binding, 122

Protein Precipitation, 70

Puerarin, 255

Pyranocoumarins, 156

Pyrrolizidine Alkaloid, 216

Quantification, 68

Radix Astragali, 173

Radix Paeoniae Alba, 257

Radix Paeoniae Rubra, 257

Ramulus Cinnamomi, 89

Rat, 56, 59, 290

Reactive Metabolite Identification, 204

Reactive Metabolites, 198

Receptor Binding Kientic Model, 248

Receptor Occupancy, 248

Receptors/nuclear receptors, 95, 108, 137, 164, 175, 263, 273, 304, 306, 308, 337

Renal Secretion, 271

Repeated Administration, 333

Reserpine, 150

Rhodamine 123, 75

Safety Testing, 111

Salt, 337

Scutellariae Radix, 121

Shaoyao-Gancao-Tang, 149

Shengmai injection, 82

Signal Transduction, 128

Sijunzi Decoction, 150

Sophorae Flos decoction, 266

Spontaneously Hypertensive Rats, 173, 333

Stereoselective Metabolism, 44, 187, 250, 310, 311

Structural Identification, 81

Substrate Recognition, 333

Sudoxicam, 208

Suppository, 242

Tanshinone, 105, 292

Targeting, 264

Tea Ployphenols, 103

Time-dependent Pharmacokinetics, 154

Tissue Distribution, 52, 121, 220

Tissue Plasminogne Activator, 124

Total Panax Notoginsenoside(TPNs), 119

Toxicity, 170

Toxicokinetics, 194, 279

Traditional Chinese Medicine, 82, 89, 194, 299, 300

Traditional Medicine, 83

Transporters, 53, 56, 88, 122, 123, 136, 139, 140, 141, 142, 146, 162, 164, 171, 177, 229, 230, 252, 310, 312, 313, 315, 318, 320, 322, 323, 324, 326, 327, 329, 330, 331, 334, 336, 340, 338

Tropisetron, 70

Uric acid, 338

Urine, 268

Xenobiotic Toxicities, 209

 Xiexin Decotion, 299, 300

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.